Hematology

Clinical whole-genome sequencing of children with cancer demonstrated significant benefits, leading to improved patient management and treatment decisions.

New research on multiple myeloma provides a comprehensive proteogenomic analysis, revealing novel prognostic markers and potential therapeutic targets.

A new drug developed at the Brain Tumour Research Centre of Excellence at the University of Plymouth has shown promise in inhibiting tumour cell growth.

Researchers concluded in a new, study that an AI-powered method for detecting circulating tumour DNA, has revealed greater sensitivity than standard methods.

Recent research suggests that neutrophils may play a crucial role in cytokine release syndrome, a severe and life-threatening side effect of CAR-T therapy.

New research shows the role of JAK inhibitors in boosting immune responses against cancer.

New findings indicate the potential of Ruxolitinib as an effective treatment for steroid-refractory acute graft-versus-host disease.

A study has highlighted the clinical significance of circulating tumour cells in the blood of multiple myeloma patients, proposing a new cutoff that could enhance treatment outcomes.